Warning to my friends: If you buy and hold Transmeta (TMTA) you will
within three years turn your money into Zilch! The computer chips that TMTA has, are of a
very simple minded instruction set, but fast on par with the rest of the
chips. However, you may have to perform a hundred program steps to
accomplish what regular chips do in one. It reminds me of computers that
we used 35 years ago to get a man to the moon. In today's world Transmeta
doesn't have a chance. Try to tell that to Merrill Lynch, who must have a
bunch of favorite customers that they are trying to rescue. See Business
Week, June 18 page 116, analyst Joe Osha.
Isn't it great that this insider (shown below) got out at $12+. That was
so damn dishonest and shortly thereafter the stock dropped like a stone.
If David Ditzel does
not jump into the stock at $4 there must be something wrong. Listen to
Joseph Osha, Analyst for Merrill Lynch & Co, you will be in for a rough
ride...He says its leadership position will help boost its shares to at
least 70 over the next year or so.
He is either a total looser or just trying to help Merrill Lynch's favorite clients
get out of the stock. Very dishonest!
Good luck....humble carl
David Ditzel, CEO of Transmeta:
31-May-01 30,000
TMTA Sold at $12.55/Share.
Proceeds of $376,500.
30-May-01 70,000
TMTA Sold at $12.19/Share.
Proceeds of $853,300.
9-May-01 200,000
TMTA Sold at $12.50/Share.
Proceeds of $2,500,000.
7-May-01 100,000
TMTA Sold at $11.79/Share.
Proceeds of $1,179,000.
7-May-01 400,000
TMTA Proposed Sale (Form 144) of Restricted Shares.
Estimated proceeds of $6,000,000.
6-Nov-00 4,420,000
TMTA Initial Direct Holdings Statement |
